Eton Pharmaceuticals (ETON) Enterprise Value (2017 - 2026)
Eton Pharmaceuticals (ETON) posted Enterprise Value of -$25.9 million for Q4 2025, up 30.12% sequentially from -$37.1 million in Q3 2025, and down 73.69% YoY from -$98.6 million in Q4 2024.
Eton Pharmaceuticals (ETON) Enterprise Value (2017 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Enterprise Value for 9 years, with the latest figure at -$25.9 million in Q4 2025.
- Quarterly Enterprise Value fell 73.69% year-over-year to -$25.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$25.9 million (down 73.69% YoY) and the FY2025 annual result came in at -$25.9 million, down 73.69% from the prior year.
- Enterprise Value advanced to -$25.9 million in Q4 2025 per ETON's latest filing, from -$37.1 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$13.4 million in Q3 2022 and troughed at -$37.1 million in Q3 2025.
- A 5-year average of -$20.3 million and a median of -$19.0 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2022: Enterprise Value slumped 209.72% in 2021, then jumped 41.09% in 2022.
- Over 5 years, Enterprise Value stood at -$14.4 million in 2021, then slipped by 13.18% to -$16.3 million in 2022, then plunged by 31.17% to -$21.4 million in 2023, then soared by 30.17% to -$14.9 million in 2024, then sank by 73.69% to -$25.9 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$25.9 million, -$37.1 million, and -$25.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | -26.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.85 Mn |
| Dec 31, 2025 | -25.94 Mn |
| Sep 30, 2025 | -37.12 Mn |
| Jun 30, 2025 | -25.38 Mn |
| Mar 31, 2025 | -17.42 Mn |
| Dec 31, 2024 | -14.94 Mn |
| Sep 30, 2024 | -20.26 Mn |
| Jun 30, 2024 | -17.69 Mn |
| Mar 31, 2024 | -16.66 Mn |
| Dec 31, 2023 | -21.39 Mn |
| Sep 30, 2023 | -22.07 Mn |
| Jun 30, 2023 | -21.57 Mn |
| Mar 31, 2023 | -14.71 Mn |
| Dec 31, 2022 | -16.31 Mn |
| Sep 30, 2022 | -13.38 Mn |
| Jun 30, 2022 | -17.05 Mn |
| Mar 31, 2022 | -15.23 Mn |
| Dec 31, 2021 | -14.41 Mn |
| Sep 30, 2021 | -22.71 Mn |
| Jun 30, 2021 | -25.80 Mn |